Authors, Publishers, and Copyright Owners May Benefit from a $1.5 Billion Class Action Settlement
SEATTLE, Oct. 7, 2025 /PRNewswire/ -- JND Legal Administration A proposed class…
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinsons disease
Investigational cell therapy bemdaneprocel continues to demonstrate a favorable safety profile at…
Trinasolar Vertex N Shield module wins comprehensive reliability award from TV Rheinland
CHANGZHOU, China, Sept. 30, 2025 /PRNewswire/ -- Trinasolar announced its Vertex N…
Elham Tea House Receives Highly Recommended Rating from Renowned Tea Room Expert
Wednesday 1 October, 2025 The Elham Tea House, a charming establishment nestled…
Deals Exceeding RMB 2 Billion Follow SANY’s Showcase of Integrated Green Solutions at Mining Indonesia 2025
BEIJING, Sept. 30, 2025 /PRNewswire/ -- From September 17 to 20, 2025, SANY…
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
September 29, 2025 19:30 ET | Source: Nxera Pharma Tokyo, Japan and…
Abu Dhabi Art Fair 2025 to Host 140 Galleries From 35+ Countries
ABU DHABI, UAE, Sept. 29, 2025 /PRNewswire/ -- Organised by the Department…
Lupin Strengthens its Global Specialty Ophthalmology Business with Acquisition of VISUfarma from GHO Capital
LONDON, ROME and ZUG, Switzerland, Sept. 29, 2025 /PRNewswire/ -- Global pharma…
OXCCU Raises $28m in Series B Funding to Scale Sustainable Aviation Fuel from Waste Carbon
Backed by global leaders in aviation, energy, and climate investing, OXCCU strengthens its…
Immuneering to Discuss Recently Announced Overall Survival Data from Phase 2a Clinical Trial of Atebimetinib + mGnP in First-Line Pancreatic Cancer Patients on Monday, September 29, 2025
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX),…